Skip to Main Content

Paper Details

Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance.
Neoplasia
37
2018
-small, 6-thio, 6-thio-2'-deoxyguanosine, 6-thio-dG, EGFR, Non-Small Cell Lung Cancer, Telomerase, cancer, carboplatin, cisplatin, erlotinib, erlotinib-, paclitaxel/carboplatin-, and gemcitabine/cisplatin-resistant cells, gemcitabine, human, human xenografts, late-stage cancer, lung cancer, lung cancer human cells, mouse, nucleoside, paclitaxel, patients, telomerase, telomerase-expressing non, telomerase-expressing non-small cell lung cancer cells
Author NameAffiliation
Michael PeytonHamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center
Tsung-Po LaiUniversity of Texas Southwestern Medical Center
Lani F WuDepartment of Pharmaceutical Chemistry, University of California san francisco
Steven J AltschulerDepartment of Pharmaceutical Chemistry, University of California san francisco
John D MinnaHamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, UT Southwestern Medical Center, USA Simmons Comprehensive Cancer Center, Department of Surgery and Hamon Center for Therapeutic Oncology Research
  • 1 - 5

Datasets

Release 1.2